Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4227420

Cc1ccccc1CNCC(=O)N(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
KMT2A Q03164 4/20 0.40
HTT P42858 2/20 0.40
GAA P10253 2/20 0.40
CHRM2 P08172 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
POLQ O75417 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 1/20 0.38
GFER P55789 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5108484 0.91 GPR6 (0.39) ALDH1A1HPGDKMT2AHTTNPSR1
Trifluoroacetic Acid SCHEMBL4233867 0.85 POLQ (0.50) ALDH1A1HTTPOLQKDM4ETDP1
Trifluoroacetic Acid SCHEMBL4233596 0.85 KMT2A (0.40) ALDH1A1KMT2AHTTNPSR1MEN1
Trifluoroacetic Acid SCHEMBL5098273 0.84 TACR1 (0.45) ALDH1A1KMT2AHTTNPSR1NPC1
Trifluoroacetic Acid SCHEMBL4235529 0.83 KDM4E (0.50) ALDH1A1KMT2AGAAMEN1POLB
Trifluoroacetic Acid SCHEMBL4235482 0.82 P2RX7 (0.41) ALDH1A1KMT2AHTTNPSR1MEN1
Trifluoroacetic Acid SCHEMBL4223287 0.81 HDAC3 (0.43) ALDH1A1KMT2AHTTNPSR1MEN1
Trifluoroacetic Acid SCHEMBL4225473 0.79 LMNA (0.45) ALDH1A1HPGDKMT2AHTTNPSR1
Trifluoroacetic Acid SCHEMBL4221829 0.78 KDM4E (0.46) ALDH1A1HPGDKMT2AHTTGAA
Trifluoroacetic Acid SCHEMBL10698406 0.76 ALDH1A1 (0.53) ALDH1A1HPGDKMT2AHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096104-A1 Organic diamines as mGluR7 modulators Novartis AG (CH) 2009-09-02 EP disclosed
US-20080242698-A1 Organic Compounds NOVARTIS AG (CH) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242698-A1 Organic Compounds AOC1, OTC, ODC1 ALDH1A1 266/4885HPGD 1276/4885KMT2A 1438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.